You are here

GOP Health Care Bill Now Shrouded in Secrecy

Document kept from prying eyes after leaks

Republican congressional leaders have been keeping the latest draft of their bill to repeal Obamacare under lock and key to prevent it from being leaked to the press in the same fashion as an older version was last week, according to an article on the FierceHealthcare website. All the secrecy, however, doesn’t sit well with Senator Rand Paul (R-Kentucky), who has been a leading critic of the party’s health care proposals.

“It is already bad enough that it appears House leadership wants us to settle for ‘Obamacare Lite,’ but now we can’t even expect full transparency during the process,” he said in a statement. “I will not stand idly by while the American people are kept in the dark.”

With reporters in tow, Paul headed to the secure location where the bill was being safeguarded, but he was turned away empty-handed.

Paul’s criticism of the previous draft of the bill as well as his public move to obtain a copy of the newest version illustrate the divisions that are hampering Republicans’ health care agenda, according to the article.

But in his weekly news conference, House Speaker Paul Ryan (R-Wisconsin) was adamant that Republicans are all on the same page when it comes to repealing and replacing the Patient Protection and Affordable Care Act.

“We’re all working off the same piece of paper, the same plan, so we are in sync—the House, the Senate, and the Trump administration—because this law is collapsing,” he said. “I am perfectly confident that when it is all said and done, we are going to unify because we all, every Republican, ran on repealing and replacing, and we’re going to keep our promises.”

Sources: FierceHealthcare; March 3, 2017; and Rand Paul; March 2, 2017. 

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs